Contemporary Management of Median Arcuate Ligament in Liver Transplantation

Benoy I Babu1, Gabriel C Oniscu1

  • 1Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.

Transplantation Direct
|December 26, 2022
PubMed

Insights

Median arcuate ligament (MAL) can complicate liver transplants. A systematic review found MAL intervention reduces hepatic artery thrombosis and graft loss, proposing a new management algorithm for optimal arterial inflow.

Area of Science:

  • Hepatology
  • Vascular Surgery
  • Transplantation

Background:

  • Median arcuate ligament (MAL) syndrome can compromise arterial blood flow during orthotopic liver transplantation (OLT).
  • Standardized approaches for managing arterial inflow in OLT patients with MAL are lacking.

Purpose of the Study:

  • To systematically review the incidence, investigation, and management of MAL in OLT.
  • To propose an intraoperative algorithm for assessing and managing liver transplant arterial inflow in the presence of MAL.

Main Methods:

  • Systematic review adhering to Cochrane and PRISMA guidelines.
  • Analysis of 21 manuscripts involving 117 patients undergoing OLT with MAL.
  • Evaluation of MAL incidence, interventions, and complications.

Main Results:

  • MAL incidence in OLT ranges from 1.6% to 12%.
  • Hepatic artery thrombosis occurred in 17% of patients without MAL intervention versus 2.6% post-intervention.
  • Graft loss was 5.9% in patients with MAL; arterial stenosis occurred in 3.9% post-intervention.

Conclusions:

  • MAL intervention is associated with reduced hepatic artery thrombosis and graft loss in OLT.
  • A proposed algorithm guides intraoperative assessment and management of arterial inflow based on hepatic artery flow dynamics.
  • The algorithm suggests preserving gastroduodenal artery inflow or considering MAL release/arterial jump graft based on flow variations.

Related Concept Videos